Community-based organization perspectives on participating in state-wide community canvassing program aimed to reduce COVID-19 vaccine disparities in California.
COVID-19
COVID-19 vaccination
Community health
Community-engaged research
Health disparities
Health equity
Public health
Race/ethnicity
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
14 07 2023
14 07 2023
Historique:
received:
28
04
2023
accepted:
28
06
2023
medline:
17
7
2023
pubmed:
15
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Inequities in COVID-19 vaccine accessibility and reliable COVID-related information disproportionately affected marginalized racial and ethnic communities in the U.S. The Get Out the Vaccine (GOTVax) program, an innovative statewide government-funded COVID-19 vaccine canvassing program in California, aimed to reduce structural barriers to COVID-19 vaccination in high-risk communities with low vaccination rates. GOTVax consisted of a community-academic-government partnership with 34 local trusted community-based organizations' (CBOs) to conduct COVID-19 vaccine outreach, education, and vaccine registration. The purpose of this qualitative evaluation study was to explore the barriers and facilitators of using local CBOs to deploy a geographically, racially, and ethnically diverse state-wide COVID-19 vaccine outreach program. Semi-structured online interviews were conducted with participating GOTVax CBO leaders from November 2021 to January 2022. Transcripts were analyzed using reflexive thematic analysis. Thirty-one of 34 CBOs participated (91% response rate). Identified themes encompassed both facilitators and barriers to program participation. Key facilitators included leveraging trust through recognized entities; promoting empathetic, tailored outreach; and flexibility of milestone-based CBO funding contracts for rapid program implementation. Barriers included navigating community sociopolitical, geographic, and cultural factors; managing canvassers' safety; desiring metrics for self-evaluation of outreach success; mitigating canvassing technology challenges; and concerns of program infrastructure initially limiting outreach. CBOs problem-solved barriers with academic and government partners. Between May and December 2021, the GOTVax program reached over 2 million California residents and registered over 60,000 residents for COVID-19 vaccination. Public health campaigns may improve benefits from leveraging the expertise of community-trusted CBOs and universities by providing flexible infrastructure and funding, allowing CBOs to seamlessly tailor outreach most applicable to local minoritized communities.
Sections du résumé
BACKGROUND
Inequities in COVID-19 vaccine accessibility and reliable COVID-related information disproportionately affected marginalized racial and ethnic communities in the U.S. The Get Out the Vaccine (GOTVax) program, an innovative statewide government-funded COVID-19 vaccine canvassing program in California, aimed to reduce structural barriers to COVID-19 vaccination in high-risk communities with low vaccination rates. GOTVax consisted of a community-academic-government partnership with 34 local trusted community-based organizations' (CBOs) to conduct COVID-19 vaccine outreach, education, and vaccine registration. The purpose of this qualitative evaluation study was to explore the barriers and facilitators of using local CBOs to deploy a geographically, racially, and ethnically diverse state-wide COVID-19 vaccine outreach program.
METHODS
Semi-structured online interviews were conducted with participating GOTVax CBO leaders from November 2021 to January 2022. Transcripts were analyzed using reflexive thematic analysis.
RESULTS
Thirty-one of 34 CBOs participated (91% response rate). Identified themes encompassed both facilitators and barriers to program participation. Key facilitators included leveraging trust through recognized entities; promoting empathetic, tailored outreach; and flexibility of milestone-based CBO funding contracts for rapid program implementation. Barriers included navigating community sociopolitical, geographic, and cultural factors; managing canvassers' safety; desiring metrics for self-evaluation of outreach success; mitigating canvassing technology challenges; and concerns of program infrastructure initially limiting outreach. CBOs problem-solved barriers with academic and government partners.
CONCLUSIONS
Between May and December 2021, the GOTVax program reached over 2 million California residents and registered over 60,000 residents for COVID-19 vaccination. Public health campaigns may improve benefits from leveraging the expertise of community-trusted CBOs and universities by providing flexible infrastructure and funding, allowing CBOs to seamlessly tailor outreach most applicable to local minoritized communities.
Identifiants
pubmed: 37452299
doi: 10.1186/s12889-023-16210-9
pii: 10.1186/s12889-023-16210-9
pmc: PMC10349443
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1356Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):759-764
pubmed: 34014911
J Gen Intern Med. 2021 Jul;36(7):2130-2133
pubmed: 33754319
Rand Health Q. 2022 Jun 30;9(3):23
pubmed: 35837520
JAMA Netw Open. 2022 Jun 1;5(6):e2217875
pubmed: 35731520
JAMA Netw Open. 2021 Sep 1;4(9):e2127582
pubmed: 34591103
MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):560-565
pubmed: 33857068
PLoS One. 2022 May 12;17(5):e0266397
pubmed: 35550627
Int J Equity Health. 2017 Oct 5;16(1):178
pubmed: 28982362
Int J Environ Res Public Health. 2021 Sep 20;18(18):
pubmed: 34574827
J Public Health Manag Pract. 2011 Jan-Feb;17(1):20-7
pubmed: 21135657
Ethn Dis. 2022 Oct 20;32(4):341-350
pubmed: 36388857
Glob Health J. 2021 Mar;5(1):51-55
pubmed: 33585053
J Behav Med. 2023 Apr;46(1-2):153-166
pubmed: 35066696
JAMA Health Forum. 2021 Feb 1;2(2):e210213
pubmed: 36218794
PLoS One. 2021 Sep 20;16(9):e0257111
pubmed: 34543291
Circulation. 2019 Jan 2;139(1):10-19
pubmed: 30592662
Milbank Q. 2016 Mar;94(1):163-214
pubmed: 26994713
J Am Board Fam Med. 2021 Jul-Aug;34(4):698-708
pubmed: 34312263
N Engl J Med. 2020 Nov 5;383(19):e108
pubmed: 32966715
PLoS One. 2022 May 3;17(5):e0268020
pubmed: 35503797
Front Public Health. 2021 Apr 23;9:645268
pubmed: 33968884
Lancet Glob Health. 2021 Jun;9(6):e749-e750
pubmed: 33713634